Literature DB >> 24517588

MicroRNAs: the fine modulators of liver development and function.

Yemiao Chen1, Catherine M Verfaillie.   

Abstract

MicroRNAs are a class of small non-coding RNAs involved in the transcriptional and post-transcriptional regulation of gene expression. The function of miRNAs in liver disease including hepatocellular carcinoma (HCC), hepatitis, and alcoholic liver disease, have been widely studied and extensively reviewed. Increasing evidence demonstrates that miRNAs also play a critical role in normal liver development and in the fine-tuning of fundamental biological liver processes. In this review, we highlight the most recent findings on the role of miRNAs in liver specification and differentiation, liver cell development, as well as in the many metabolic functions of the liver, including glucose, lipid, iron and drug metabolism. These findings demonstrate an important role of miRNAs in normal liver development and function. Further researches will be needed to fully understand how miRNAs regulate liver generation and metabolic function, which should then lead to greater insights in liver biology and perhaps open up the possibility to correct errors that cause liver diseases or metabolic disorders.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  detoxification; glucose metabolism; iron metabolism; lipid metabolism; liver cells development; liver specification; microRNA

Mesh:

Substances:

Year:  2014        PMID: 24517588     DOI: 10.1111/liv.12496

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  30 in total

1.  Function and clinical potential of microRNAs in hepatocellular carcinoma.

Authors:  Lijuan Wang; Yongfang Yue; Xian Wang; Hongchuan Jin
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

Review 2.  Exosomes as Mediators of the Systemic Adaptations to Endurance Exercise.

Authors:  Adeel Safdar; Mark A Tarnopolsky
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

3.  Triple Staining Including FOXA2 Identifies Stem Cell Lineages Undergoing Hepatic and Biliary Differentiation in Cirrhotic Human Liver.

Authors:  Charles E Rogler; Remon Bebawee; Joe Matarlo; Joseph Locker; Nicole Pattamanuch; Sanjeev Gupta; Leslie E Rogler
Journal:  J Histochem Cytochem       Date:  2016-11-24       Impact factor: 2.479

4.  Loss of TSC complex enhances gluconeogenesis via upregulation of Dlk1-Dio3 locus miRNAs.

Authors:  Dritan Liko; Andrzej Rzepiela; Vanja Vukojevic; Mihaela Zavolan; Michael N Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-09       Impact factor: 11.205

Review 5.  Host cellular microRNA involvement in the control of hepatitis B virus gene expression and replication.

Authors:  Yoshiaki Mizuguchi; Toshihiro Takizawa; Eiji Uchida
Journal:  World J Hepatol       Date:  2015-04-08

6.  An HNF4α-microRNA-194/192 signaling axis maintains hepatic cell function.

Authors:  Aoi Morimoto; Mana Kannari; Yuichi Tsuchida; Shota Sasaki; Chinatsu Saito; Tsuyoshi Matsuta; Tsukasa Maeda; Megumi Akiyama; Takahiro Nakamura; Masakiyo Sakaguchi; Nobukazu Nameki; Frank J Gonzalez; Yusuke Inoue
Journal:  J Biol Chem       Date:  2017-05-02       Impact factor: 5.157

7.  miR-217 regulates ethanol-induced hepatic inflammation by disrupting sirtuin 1-lipin-1 signaling.

Authors:  Huquan Yin; Xiaomei Liang; Alvin Jogasuria; Nicholas O Davidson; Min You
Journal:  Am J Pathol       Date:  2015-03-19       Impact factor: 4.307

8.  MiR-17-92 cluster promotes hepatocarcinogenesis.

Authors:  Hanqing Zhu; Chang Han; Tong Wu
Journal:  Carcinogenesis       Date:  2015-08-01       Impact factor: 4.944

9.  Integrated analysis of microRNA and mRNA expression profiles highlights the complex and dynamic behavior of toosendanin-induced liver injury in mice.

Authors:  Xiaoyan Lu; Cai Ji; Wei Tong; Xueping Lian; Ying Wu; Xiaohui Fan; Yue Gao
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

10.  Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.

Authors:  Kiyoshi Migita; Atsumasa Komori; Hideko Kozuru; Yuka Jiuchi; Minoru Nakamura; Michio Yasunami; Hiroshi Furukawa; Seigo Abiru; Kazumi Yamasaki; Shinya Nagaoka; Satoru Hashimoto; Shigemune Bekki; Hiroshi Kamitsukasa; Yoko Nakamura; Hajime Ohta; Masaaki Shimada; Hironao Takahashi; Eiji Mita; Taizo Hijioka; Haruhiro Yamashita; Hiroshi Kouno; Makoto Nakamuta; Keisuke Ario; Toyokichi Muro; Hironori Sakai; Kazuhiro Sugi; Hideo Nishimura; Kaname Yoshizawa; Takeaki Sato; Atsushi Naganuma; Tatsuji Komatsu; Yukio Oohara; Fujio Makita; Minoru Tomizawa; Hiroshi Yatsuhashi
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.